OR WAIT null SECS
December 12, 2018
The $62-billion acquisition of Shire by Takeda Pharmaceutical was approved by both sets of shareholders.
December 05, 2018
GSK and TESARO have entered into a definitive agreement concerning GSK's acquisition of TESARO for an aggregate cash consideration worth approximately $5.1 billion.
November 30, 2018
The acquisition will give Genentech full rights to Jecure’s preclinical portfolio of NLRP3 inhibitors.
November 20, 2018
With the $252-million acquisition of contract development, manufacturing, and testing organization Avista Pharma Solutions, Cambrex will enter the market for early stage small-molecule development and testing services.
November 08, 2018
Ardena has moved into its expanded headquarters, located in Gent, Belgium, as a result of continued growth.
November 01, 2018
he acquisition expands the company’s formulation and analytical R&D services.
October 18, 2018
Novartis plans to acquire Endocyte, a biopharmaceutical company, to accelerate the development of innovative radioligand technology for treating cancer.
October 11, 2018
Roche has acquired Tusk Therapeutics in a deal worth up to EUR 659 million (US$762 million).
October 10, 2018
The company’s three acquisitions over the last 12 months have increased its global presence, expanding its European footprint and bringing new localized services in Asia-Pacific and the west coast of the United States.
October 01, 2018
The divestiture of the European generic-drug business of Sanofi-Zentiva-to Advent International has been completed.